The Pollypill Could Reduce Cardiovascular Disease by 80 Percent

Published: February, 2004

BOSTON , Feb. 11 /PRNewswire/ -- More than 675,000 people die each year from heart disease and stroke in the United States . Although notable gains have been made in prevention and treatment, according to Dr. Harvey B. Simon, editor of the Harvard Men's Health Watch, there is more to do. The March issue of the newsletter discusses a proposal for the Pollypill, a medication that may have long-term benefits for those at risk for heart disease and stroke.

The Pollypill is not yet on the market, but clinical trials show this drug may reduce the risk of these illnesses by more than 80 percent and possibly add 11 years of life to those who take it. A single tablet contains six different medications: a statin, three types of blood pressure medications, folic acid, and a small dosage of aspirin.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »